Stojnev S, Krstic M, Ristic-Petrovic A, et al. Gastric cancer stem cells: therapeutic targets[J]. Gastric Cancer, 2014, 17(1): 13-25. [2]Yang L, Ping Y F, Yu X, et al. Gastric cancer stem-like cells possess higher capability of invasion and metastasis in association with a mesenchymal transition phenotype[J]. Cancer Lett, 2011, 310(1): 46-52. [3]汤钊猷. 癌转移研究的几个重要问题[J]. 中华消化外科杂志, 2014, 13(3): 161-164. [4]赖章超, 宋鑫. 肌切蛋白的结构与功能多样性[J]. 中国生物化学与分子生物学报, 2012, 28(7): 617-623. [5]Silacci P, Mazzolai L, Gauci C, et al. Gelsolin superfamily proteins: key regulators of cellular functions[J]. Cell Mol Life Sci, 2004, 61(19/20): 2614-2623. [6]Abouzahr S, Bismuth G, Gaudin C, et al. Identification of target actin content and polymerization status as a mechanism of tumor resistance after cytolytic T lymphocyte pressure[J]. Proc Natl Acad Sci U S A, 2006, 103(5): 1428-1433. [7]Miura N, Takemori N, Kikugawa T, et al. Adseverin: a novel cisplatin-resistant marker in the human bladder cancer cell line HT1376 identified by quantitative proteomic analysis[J]. Mol Oncol, 2012, 6(3): 311-322. [8]吴海福. Scinderin基因在结直肠癌肝转移中的相关功能研究 [D]. 上海: 复旦大学, 2010. [9]吴姗, 马晶晶, 姜旖, 等. 卵巢上皮性癌中肌切蛋白的表达及其临床意义[J]. 实用妇产科杂志, 2013, 29(7): 522-525. [10]Chen X M, Guo J M, Chen P, et al. Suppression of scinderin modulates epithelial-mesenchymal transition markers in highly metastatic gastric cancer cell line SGC-7901[J]. Mol Med Rep, 2014, 10(5): 2327-2333.